Measles cases in Pennsylvania remain low amid national outbreak, but vaccine hesitancy lays groundwork for spread
This story first appeared in How We Care, a weekly newsletter by Spotlight PA featuring original reporting and perspectives on how we care for one another at all stages of life. Sign up for free here.
This year marked the first death from measles in the United States since 2015 — and the second and third too. Amid a major outbreak in the Southwest, the CDC has confirmed over 700 cases of the highly contagious viral illness since the beginning of 2025, the most in five years.
Pennsylvania hasn't seen any deaths, but nine measles cases have been reported across at least five counties — Bucks, Erie, Lancaster, Montgomery, and Philadelphia — as of last week.
To learn more about the illness and how an outbreak would impact Pennsylvania, Spotlight PA spoke with Amesh Adalja. The doctor and Johns Hopkins professor, who lives near Pittsburgh, is an expert on pandemics and infectious diseases. The following conversation has been edited for clarity and length.
Spotlight PA: The United States has seen twice as many measles cases this year than it did all of last year. What's causing this?
Amesh Adalja: Predominantly, the cause has been a major outbreak in Texas involving a very under-vaccinated population, the Mennonite. That outbreak accounts for the bulk of the cases that we're seeing in the United States right now.
How do you think that we should be responding to this? Both in a broad sense, but also as individuals who might be feeling concerned by this news?
There's no magic to measles. This is a problem that science and medicine had solved in the 1960s. The way that you extinguish a measles outbreak is by getting a high percentage of the population in a given community vaccinated. So the key message from everyone has to be that those individuals who are not vaccinated against measles — anywhere in this country, but particularly in these outbreak zones — need to get vaccinated. That's how we put this to an end. It's not challenging in the sense that there's not some specific solution that needs to be created.
I want to ask about vaccination here in Pennsylvania. The kindergarten vaccination rates for measles have been dropping — the rate was 96.4% in the 2019-2020 school year, but as of the 2022-2023 school year, it was 94%. Why are we seeing this drop?
The drop is multifactorial. Some of it had to do with catching up because of disruptions that occurred during COVID-19, and some children fell off of the routine childhood immunization. But also an aspect of it has to be the growing anti-vaccine sentiment that has been increasing over time and really accelerated during COVID-19. That vaccine hesitancy was initially directed against COVID-19 vaccines, but it has basically metastasized and now affects all vaccines.
Which parts of Pennsylvania would be most vulnerable to the impact of an outbreak if one were to happen?
Certain select populations where we know that they have lower than average vaccination rates — which would be, for example, Orthodox Jewish communities, Mennonite, Amish, and related groups where the vaccination rates may be suboptimal as well — those are going to be the most susceptible to the outbreaks occurring. But that's not always the case. The cases that we had back in 2024 and 2023 were related to people who voluntarily didn't vaccinate, and that was in the Philadelphia metro area.
What happens is, the virus is gonna spread really efficiently if it finds a population that's under-vaccinated, and that population is geographically cloistered, like the Mennonites in Gaines County, Texas. Anywhere you see that kind of concentration of low vaccination numbers, that's going to be a hyper-susceptible area. It will be kindling. If you think of the virus as kind of a fire, that's a lot of kindling that's in one given area.
Pennsylvania's Department of Health doesn't make all measles cases public, but rather does so in situations where it isn't able to reasonably identify people who are possibly exposed. Is this a typical approach? What are the benefits and drawbacks?
It's not as if the numbers aren't tallied. It's that they don't … put a press release out for every case. In general, the more transparency we have, the better it is, and the more situational awareness health care providers have of measles cases in their area, the better. Because … it's not something that's part of the everyday experience of physicians. So I think it's really important that when there is a measles case that it's announced publicly, and not just kind of added to the number and part of a graph somewhere.
Even if it's a one-off case … I think it's important that people have awareness, because one of the things that's fueled vaccine hesitancy is that we sort of live in a luxury of not having to think about measles.
There have been major cuts at the U.S. Department of Health and Human Services, the CDC, the NIH, and then there were also some attempted cuts to federal funding for Pennsylvania health departments that have been put on hold by a judge for now. Do any of these — or the uncertainty created by them — affect the work of tracking measles cases or providing care?
Yes, because a lot of times certain grants that are being given to local and state health departments from the federal government are going to be used for some of their ordinary operational activities. When that funding is not there, they have less resources to be able to respond to these outbreaks, to perform their daily operations. I think it's important to keep in mind that most local health departments are underfunded and understaffed, and they rely upon some of those federal grants in order to do their core functions.
So when there's disruptions in that funding or uncertainty about that funding, it does directly impact their ability to perform these activities, which could include contact tracing, it could include press releases, it could include setting up vaccination clinics, diagnostic testing. All of those things that are essential to the response are going to be jeopardized when there's not a clear source of funding or when that funding is uncertain.
What does a measles case look like, and if somebody suspects that they or someone they're caring for might be infected, what's the next step?
Measles is a respiratory virus, so it will usually begin with what we call the three C's: that stands for cough, coryza — which is a fancy word for runny nose — and conjunctivitis, which means a red eye. And then you get that characteristic rash.
If someone thinks someone they're caring for has measles, first of all, as long as they're vaccinated — the carer, or the person that's exposed — they're fine. If they're not vaccinated or only partially vaccinated, there's going to be actions to take. If you suspect someone that you're around has measles, you should encourage them or arrange for them to get testing to actually confirm that it is measles. That's the key thing. Obviously, if they're running into trouble — if they have unremitting fever, they're very fatigued, they're short of breath — those are things that are going to require immediate medical attention.
If you learned something from this article, pay it forward and contribute to Spotlight PA at spotlightpa.org/donate. Spotlight PA is funded by foundations and readers like you who are committed to accountability journalism that gets results.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis
Super-high-yield stocks often deliver heaps of passive income early on, but they aren't famous for rapid payout raises. Pfizer offers a sky-high yield, but its payout has been rising slowly. Prologis offers a decent yield, and it's been raising its payout at an exciting pace. 10 stocks we like better than Prologis › Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Should you chase high yields from slow-growing businesses or invest in lower-yield providers with more predictable cash flows? Lately, Pfizer (NYSE: PFE) and Prologis (NYSE: PLD) have been perfect examples of the trade-off between attractive yields and dividend growth. Pfizer offers a sky-high yield that's climbing slowly. Prologis offers a much lower yield, but it's been raising its payout at a remarkable pace. Here's a closer look at both to help you decide which one fits your goals. Shares of Pfizer have fallen about 62% from their COVID-19 pandemic highs. The stock is way down, but the company has raised its payout every year since 2009. At its beaten-down price, this stock offers an eye-popping 7.3% dividend yield. Pfizer's COVID-19 vaccine, Comirnaty, and antiviral treatment, Paxlovid, drove adjusted earnings up to $6.58 per share in 2022. Sinking demand for COVID-19 vaccines and treatments reduced adjusted earnings to just $3.11 per share last year. In 2025, Pfizer expects a significant earnings contraction. At the midpoint of the guided range management provided this April, adjusted earnings are expected to fall by 6.8% this year. The $2.80 per share management expects at the low end of the guided range is more than enough to support a dividend payout currently set at an annualized $1.72 annually, but there could be further contractions ahead. Eliquis is a next-generation blood thinner that Pfizer markets in collaboration with Bristol Myers Squibb. It's currently responsible for 14% of Pfizer's total revenue and is likely to lose ground to generic competition in the lucrative U.S. market in 2028. Long before Eliquis loses ground to generic competition, the company's lead growth driver, Vyndaquel, could stumble. BridgeBio launched a competing treatment called Attruby in late 2024, and it's been exceeding expectations. Pfizer's facing patent cliffs, but it also has one of the most productive development pipelines in the industry. Last year alone, the Food and Drug Administration issued more than a dozen approvals to new Pfizer treatments and several that are already on the market. With plenty of new products to market, the drugmaker has a good chance to continue its payout-raising streak in the decade ahead. As more folks do their shopping online, demand for warehouses that can support e-commerce has soared. By anticipating the demand, Prologis has become the world's largest real estate investment trust (REIT) that everyday investors can buy shares of. Fear and uncertainty regarding the taxes businesses need to pay when importing goods to the U.S. have pressured the stock. It's down about 12% from a peak it set in March. At its beaten-down price, it offers a 3.7% yield. Prologis has been able to raise its dividend by 11.7% annually over the past five years. At this pace, investors who buy at recent prices could begin receiving a double-digit yield on cost in less than a decade. Amazon, Home Depot, and FedEx are Prologis' largest customers. These three tenants are responsible for only 8.2% of the rent payments Proligis receives every month. This high level of diversification is a big reason it can boast industry-leading credit ratings. With an A2 rating from Moody's and an A rating from S&P Global, the weighted average interest rate on Prologis' outstanding debts was just 3.1% at the end of March. Acquiring and developing properties is an important part of this REIT's business, but it also acts as a lender. With an enviable credit rating, it can produce a strong profit while offering rates that its smaller competitors can't match. For companies that own their warehouses, selling them to Prologis and leasing them back is often their lowest-cost source of capital. With the vast majority of the world's logistics real estate still owned by the companies that use it, Prologis could continue growing at a rapid pace for decades to come. Pfizer offers a yield that's almost twice as high as Prologis's, but the pharmaceutical giant has been raising its payout at less than half the pace of the logistics REIT. Pfizer might be a good option for folks near retirement age. For income-seeking investors, though, Prologis seems like the better dividend stock to buy now. Before you buy stock in Prologis, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Prologis wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $656,825!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $865,550!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Cory Renauer has positions in Amazon. The Motley Fool has positions in and recommends Amazon, Bristol Myers Squibb, FedEx, Home Depot, Moody's, Pfizer, Prologis, and S&P Global. The Motley Fool recommends BridgeBio Pharma and recommends the following options: long January 2026 $90 calls on Prologis. The Motley Fool has a disclosure policy. Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Time Business News
18 minutes ago
- Time Business News
Why More Parents Are Turning to ADHD Coaching for Teens
According to the Centers for Disease Control and Prevention (CDC), an estimated 11.4% of U.S. children aged 3–17 years—about 7.1 million children—have been diagnosed with attention-deficit/hyperactivity disorder (ADHD) as of 2022. The diagnosis is more common among boys (16.3%) than girls (6.5%). ADHD prevalence also varies by demographic factors. For many of these students, academic struggles are only part of the picture. Challenges with executive function—skills like organization, time management, and task initiation—impact nearly every aspect of daily life. Research shows that around 70% of individuals with ADHD report significant improvements in executive functioning skills after engaging in ADHD coaching (Psychology Today). Programs like offer one-on-one ADHD coaching in South Carolina and online to help students build lasting strategies for success in school and life. While schools play a vital role in providing accommodations and support services, they are often stretched thin. Many schools offer 504 Plans or Individualized Education Programs (IEPs), but these focus primarily on classroom modifications and academic goals. Outside of school, parents are finding there are limited options for building real-world skills that help teens thrive beyond the classroom. This is where ADHD coaching is stepping in to fill the gap. ADHD coaching for teens is a growing field designed to help students understand how their brain works best—and how to develop strategies that match their unique learning and thinking styles. Rather than focusing solely on academic content, coaching helps teens build foundational life skills: organizing assignments, managing time, starting tasks, and handling distractions. Many parents turn to coaching because they see their teens struggling with challenges that aren't fully addressed at school: A student who forgets homework, even with reminders A teen overwhelmed by large projects that require planning A bright child whose grades don't reflect their abilities due to executive function difficulties One recent survey by ADDitude Magazine found that over 50% of parents of children with ADHD seek out services outside of school to help their child manage symptoms and develop life skills. ADHD coaching is increasingly one of the top choices, as it offers personalized, one-on-one support that complements existing school services. In South Carolina and beyond, this trend is gaining momentum. 'We're seeing more families reach out not because their child can't learn, but because they know their child needs a different kind of support to unlock their potential,' says the team at Carolina ADHD Coaching. 'Coaching provides a safe, supportive space for students to learn skills they'll use for life—not just for school.' For parents exploring ADHD coaching, the process often begins with an initial consultation to discuss their child's needs and goals. From there, coaching sessions focus on building practical strategies, reinforcing positive habits, and empowering students to take ownership of their growth. As awareness of ADHD and executive function challenges continues to grow, more families are looking beyond the classroom to give their teens the tools they need to succeed. ADHD coaching is helping bridge that gap—and for many students, it's making all the difference. TIME BUSINESS NEWS
Yahoo
40 minutes ago
- Yahoo
Wastewater helping track spread of measles in GA
As measles cases continue to rise across the US, researchers are now using sewage wastewater to track the virus. It's testing similar to what scientists did during the COVID-19 pandemic. Sewage was tested for virus particles that helped identify early signs of increasing transmission. Measles cases could potentially be identified days before people show symptoms or have to go to a doctor. [DOWNLOAD: Free WSB-TV News app for alerts as news breaks] The new program is available for use at dozens of wastewater treatment plants in 40 states. In Georgia, they'll be testing in College Park and Columbus. In Fulton County, they'll be testing at Big Creek, Johns Creek, and Little River facilities. And in Atlanta, they'll be testing at R.M. Clayton, South River, and Utoy Creek facilities. As of Wednesday, nearly 1,100 measles cases have been reported in the US, with three deaths confirmed. In Georgia, there have not been any confirmed cases since May 19, and up until that date, there were four cases so far this year in Georgia. TRENDING STORIES: Trump announces travel ban and restrictions on 19 countries set to go into effect Monday Case of mistaken identity ends with young mother killed in alleged Atlanta gang shooting Doorbell camera captures man dragging dog down street in Fulton County [SIGN UP: WSB-TV Daily Headlines Newsletter]